Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 29, 2023
Discovery & Translation

Turning cancer drivers into cell death drivers; plus LNPs to edit stem cells and more

BioCentury’s roundup of translational innovations
BioCentury | Sep 16, 2022
Discovery & Translation

A selective JAK-1 inhibitor; plus deep learning methods to explore new protein designs and more

BioCentury’s roundup of translational news
BioCentury | Feb 21, 2018
Distillery Therapeutics

Gastrointestinal

BioCentury | Dec 15, 2017
Preclinical News

A new role for Bcl-XL in fibrosis

BioCentury | Aug 9, 2017
Distillery Therapeutics

Autoimmune disease; inflammation

BioCentury | Apr 14, 2011
Distillery Therapeutics

Indication: Gastrointestinal disease

BioCentury | Oct 23, 2008
Distillery Therapeutics

This Week in Therapeutics

Items per page:
1 - 7 of 7
Username